15228-Bladder Cancer-NA-517

Bladder Cancer

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Address

3700 W State Route 89A
Sedona, AZ 86336
P: (928) 204-4163

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.